These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11111384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D.
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A randomized study comparing cisplatin alone or combined in the palliative treatment of carcinoma of the head and neck. Analysis of a series of 209 patients].
    Chauvergne J, Cappelaere P, Fargeot P, Meeus L, Gary-Bobo J, Klein T, Clavel B, David M.
    Bull Cancer; 1988 Dec; 75(1):9-22. PubMed ID: 2451954
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N, Tahara M, Kadowaki S, Fuse N, Doi T, Minami H, Ohtsu A.
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [Abstract] [Full Text] [Related]

  • 8. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.
    Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA.
    J Clin Oncol; 2004 Jan 15; 22(2):262-8. PubMed ID: 14722034
    [Abstract] [Full Text] [Related]

  • 9. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
    Ervin TJ, Weichselbaum R, Miller D, Meshad M, Posner M, Fabian R.
    Cancer Treat Rep; 1981 Jan 15; 65(9-10):787-91. PubMed ID: 6168371
    [Abstract] [Full Text] [Related]

  • 10. [Initial polychemotherapy in the treatment of cancers of the head and neck. The efficacy and tolerance of 2 nonrandomized combinations in 48 patients].
    Brun B, Mazeron JJ, Martin M, Lelièvre G, Langlois A, Feuillade F, Lebourgeois JP, Peynegre R, Grellet M, Pierquin B.
    Bull Cancer; 1984 Jan 15; 71(1):30-4. PubMed ID: 6201214
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin alone or combined with radiotherapy in advanced head and neck cancer.
    Kuten A, Zidan J, Cohen Y, Robinson E.
    Cancer Treat Rep; 1983 Jun 15; 67(6):573-4. PubMed ID: 6190559
    [Abstract] [Full Text] [Related]

  • 13. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Faivre S, Marti A, Rixe O, Janot F, Julieron M, Gatineau M, Temam S, Armand JP, Domenge C, Luboinski B, Raymond E.
    Head Neck; 2005 Apr 15; 27(4):311-9. PubMed ID: 15700290
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 15; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 15. [Palliative antineoplastic chemotherapy of patients with head and neck tumors].
    Kleemann D, Hingst V, Kramp B.
    HNO; 1994 May 15; 42(5):275-9. PubMed ID: 7519592
    [Abstract] [Full Text] [Related]

  • 16. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
    Pouillart P, Palangie T, Garcia-Giralt E, Jouve M, Bataini JP, Jaulerry M, Brugère J, Asselin B.
    Bull Cancer; 1980 May 15; 67(3):269-80. PubMed ID: 6157447
    [Abstract] [Full Text] [Related]

  • 17. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
    Abele R, Honegger HP, Wolfensberger M, Grossenbacher R, Mermillod B, Cavalli F.
    Prog Clin Biol Res; 1985 May 15; 201():169-75. PubMed ID: 2419916
    [No Abstract] [Full Text] [Related]

  • 18. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 19. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA.
    J Clin Oncol; 2006 Mar 01; 24(7):1064-71. PubMed ID: 16505425
    [Abstract] [Full Text] [Related]

  • 20. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
    Maguire PD, Meyerson MB, Neal CR, Hamann MS, Bost AL, Anagnost JW, Ungaro PC, Pollock HD, McMurray JE, Wilson EP, Kotwall CA.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):698-704. PubMed ID: 14967423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.